Protein ingredients are ingredients extracted in the form of hydrolysates, concentrates, and isolates from protein-rich plants and animal sources to serve various application industries. This study aims to provide the overview of different types of protein ingredients: Animal protein ingredients and plant protein ingredients. The geographic scope of this study is global and includes the following regions

The non-invasive liquid biopsy technique uses samples such as stool, urine, saliva, and other samples, which are extracted without inserting any medical device into the patient’s body. These samples help healthcare professionals to identify biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), circulating messenger RNA (mRNA), circulating microRNA (miRNA), DNA methylation-based biomarkers, exosomes, and extracellular vesicles (EVs). Extensive research is being conducted worldwide for the discovery and presence of novel biomarkers in these samples, which is expected to support the healthcare continuum to conduct liquid biopsy without penetrating any minimally invasive device into the patient’s body.

Vaccine is a substance used to stimulate the production of antibodies and provide immunity against one or several diseases. Vaccines stimulate the body’s own immune system to protect the person against subsequent infection or disease. Vaccines are prepared from the causative agent of a disease, its products, or a synthetic substitute, treated to act as an antigen without inducing the disease. The report provides market dynamics and trends related to the global novel vaccine delivery system market. The study estimates the revenue generated from the sales of novel vaccine delivery system products such as syringe, needle-free injection systems, and others.

The market dynamics section of the report examines the diverse factors which govern the process of manufacturing, distribution, and usage of nucleic acid therapies globally. This analysis provides an in-depth understanding of the present and the future directions in which the market is headed and the impact of various factors on the same. This chapter covers the major market dynamics, namely, the drivers, challenges, business strategies, corporate strategies, and opportunities, analyzing several factors that positively and negatively affect the global nucleic acid therapeutics CDMO market.

An organ transplant is a surgical procedure to replace a healthy organ from a damaged organ. Organ transplant diagnostics are clinical diagnostic tools that help to improve the efficiency of transplantation procedures. HLA typing is of utmost importance in applications such as organ and blood stem cell transplantation. Organs that have been successfully transplanted include the kidneys, heart, liver, lungs, pancreas, and bone marrow transplants. The current study aims to assess the global organ transplant diagnostics market by focusing on products (kits, assays, and consumables) and services catering to end-users, including hospitals and transplants centers, academics and research centers, among others. The current market for organ transplant diagnostics is majorly dominated by manufacturers and service providers such as Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Thermo Fisher Scientific Inc. (One Lambda), bioMérieux S.A., Illumina, Inc., CareDx, Inc. and Laboratory Corporation of America Holdings.

The global ophthalmic drug delivery devices market is fragmented in nature, owing to the presence of various key drug delivery device companies. The major companies operating in the market include Aero Pump GmbH, Aptar Group, Inc., Bausch Health Companies Inc., Nemera, Ocular Therapeutix, Inc., and Gaplast GmbH. The companies offer a diverse product portfolio, including eyedroppers, squeeze dispensers, pre-filled and pre-fillable syringes, contact lenses, and ocular inserts. Furthermore, owing to the increasing technology penetration, various novel drug-device companies such as Kedalion Therapeutics, Inc., Re-Vana Therapeutics, Mati Therapeutics, Inc., Biocorp, and Ocumedic, Inc. have also entered the market.

3D printing is also known as additive printing technology, which allows manufacturers to build models using a variety of printing materials. Materials used for 3D printing include various types of polymers, metals, ceramics, and others. These printers feature extremely fine resin prints, utilizing a liquid base that is solidified using a UV light to create the solid objects. Personal 3D printers differ from professional-grade printers, in that they are much less expensive and the software needed to run them is much more user-friendly.

This study analyzes the global market for plastic, glass, aluminum, rubber and paper-based primary pharmaceutical packaging materials that include bottles, blister and strip packs, ampoules and vials, prefilled syringes, cartridges, tubes, canisters, caps and closures, and sachets. •These products are greatly valued in the pharmaceutical industry for storing and dispensing oral drugs, drops and sprays, topical medicines and suppositories, and injectables.

结核病由结核分枝杆菌感染引起，是一类慢性、传染性和致命性的疾病。随着耐多药和广泛耐药结核分枝杆菌的不断出现与快速传播，结核病治疗变得更加艰难，寻找新药成为当务之急。本文介绍近年来抗结核新药的研发进展。

The global pharmaceutical quality management software market has been segmented on the basis of application into corrective action preventive action (CAPA) management, audit management, document management, change management, training management, risk management, complaints management, regulatory and compliance management, non-conformances handling, supplier quality management, inspection management, equipment management, and others. The following figure indicates the different application types in the global pharmaceutical quality management software market along with the corresponding sub-segments.